




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Arrhythmias and Clinical EP</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=8bf30cda-f1ad-4ac5-aba0-91e57241c655</link>
        <description>Clinical Topic Feed: Arrhythmias and Clinical EP</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Top Trials from ESC 26</title>
<link>/Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at some of the important trials presented at this year&#226;€™s European Society of Cardiology (ESC) Congress.</description>
                    <pubdate>1788961680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC/AHA Scientific Statement Focuses on CV Risk Evaluation, Management For Tactical Athletes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/03/15/11/ACC-AHA-Scientific-Statement-Focuses-on-CV-Risk-Evaluation-Management-For-Tactical-Athletes</link>                    <description>A new ACC/AHA Scientific Statement provides the first comprehensive framework for cardiovascular evaluation and management of tactical athletes, including the more than 4 million Americans currently serving as military personnel, firefighters, law enforcement officers, EMS professionals, pilots and astronauts.</description>
                    <pubdate>1788458400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement from the American College of Cardiology and the American Heart Association</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.07.003</link>                    <description></description>
                    <pubdate>1788458400000</pubdate>
                    <category>Guidelines</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For September 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1788305160000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Lifestyle Intervention Effective in Prediabetes; Aficamten Tops Metoprolol For Exercise in oHCM; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1788264540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DISCO, LAACS-2, PRAGUE-26, HeartRunner: Insights on Cardiac Arrest, PE, and Surgical Outcomes</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-902am-disco-laacs2-prague26-heartrunner-esc-2026</link>                    <description>Hot Line studies from ESC Congress 2026 highlight the complexity of improving cardiovascular outcomes, with new evidence refining the role of immediate coronary angiography after cardiac arrest, identifying which patients benefit from left atrial appendage (LAA) closure during cardiac surgery, advancing treatment options for pulmonary embolism (PE), and questioning the impact of community first-responder activation on short-term cardiac arrest survival.</description>
                    <pubdate>1788182580000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ASPIRED, DANISH-CRT, and His-Alternative II Examine Syncope, CRT Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-315am-comboep-esc-2026</link>                    <description>Three Hot Line trials from ESC Congress 2026 &#226;€“ ASPIRED, DANISH-CRT, and His-Alternative II &#226;€“ test 14-day ECG monitoring in patients with unexplained syncope, compare cardiac resynchronization therapy (CRT) modalities, and assess targeted left ventricular lead placement at the site of latest electrical activation in patients with heart failure and prolonged QRS.</description>
                    <pubdate>1788168300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ESC Releases New Guidelines For Cardiac Rehab, CKD and HF</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-guidelines-esc-2026</link>                    <description>The European Society of Cardiology (ESC) released three major guideline updates during ESC Congress 2026 related to cardiac rehabilitation, chronic kidney disease (CKD) and heart failure (HF).</description>
                    <pubdate>1788164580000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IDEAL-AF, NEXAF, PVI-SHAM-AF Provide New Evidence on Interventions That Could Improve AFib Management</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-11am-comboaf-esc-2026</link>                    <description>Three new studies presented during ESC Congress 2026 are shedding light on how best to treat and manage atrial fibrillation (AFib). From catheter ablation strategies to rhythm-control procedures and tailored exercise programs, the IDEAL-AF, NEXAF and PVI-SHAM-AF trials provide fresh evidence on interventions that could improve outcomes and quality of life.</description>
                    <pubdate>1788102900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PADN-HF-PH: Pulmonary-Artery Denervation For Pulmonary Hypertension Associated With Left Heart Disease and HF</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-324am-padn-esc-2026</link>                    <description>Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension associated with left heart disease and heart failure (HF), based on findings from the PADN-HF-PH trial presented at ESC Congress 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1788082020000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>